-
1
-
-
0342674305
-
Psychoactive drugs in mental retardation
-
J. L. Matson & F. Andrasik (Eds.), New York: Plenum Press
-
Aman, M. G. (1983). Psychoactive drugs in mental retardation. In J. L. Matson & F. Andrasik (Eds.), Treatment issues and innovations in mental retardation (pp. 455-513). New York: Plenum Press.
-
(1983)
Treatment Issues and Innovations in Mental Retardation
, pp. 455-513
-
-
Aman, M.G.1
-
2
-
-
0001824107
-
Patterns of drug use, methodological considerations, measurement techniques, and future trends
-
M. G. Aman & N. N. Singh (Eds.), New York: Springer-Verlag
-
Aman, M. G., & Singh, N. N. (1988). Patterns of drug use, methodological considerations, measurement techniques, and future trends. In M. G. Aman & N. N. Singh (Eds.), Psychopharmacology of the developmental disabilities (pp. 1-28). New York: Springer-Verlag.
-
(1988)
Psychopharmacology of the Developmental Disabilities
, pp. 1-28
-
-
Aman, M.G.1
Singh, N.N.2
-
3
-
-
0002444784
-
Pharmacological interventions
-
J. L. Matson & J. A. Mulick (Eds.), New York: Pergamon Press
-
Aman, M. G., & Singh, N. N. (1991). Pharmacological interventions. In J. L. Matson & J. A. Mulick (Eds.), Handbook of mental retardation (pp. 347-372). New York: Pergamon Press.
-
(1991)
Handbook of Mental Retardation
, pp. 347-372
-
-
Aman, M.G.1
Singh, N.N.2
-
4
-
-
0027475985
-
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenia
-
Chouinard, G., Jones, B., Remington, G., Bloom, D., Addington, D., MacEwan, G. W., Labelle, A., Beauclair, L., & Arnott, W. (1993). A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenia. Journal of Clinical Psychopharmacology, 13, 5-40.
-
(1993)
Journal of Clinical Psychopharmacology
, vol.13
, pp. 5-40
-
-
Chouinard, G.1
Jones, B.2
Remington, G.3
Bloom, D.4
Addington, D.5
MacEwan, G.W.6
Labelle, A.7
Beauclair, L.8
Arnott, W.9
-
5
-
-
0028096538
-
Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia
-
Grant, S., & Fitton, A. (1994). Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs, 48, 253-273.
-
(1994)
Drugs
, vol.48
, pp. 253-273
-
-
Grant, S.1
Fitton, A.2
-
7
-
-
0029026941
-
The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A PET study
-
Kapur, S., Remington, G., Zipursky, R. B., Wilson, A. A., & Houle, S. (1995) The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A PET study. Life Sciences, 57, 103-107.
-
(1995)
Life Sciences
, vol.57
, pp. 103-107
-
-
Kapur, S.1
Remington, G.2
Zipursky, R.B.3
Wilson, A.A.4
Houle, S.5
-
8
-
-
0027318059
-
Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors
-
Leysen, J. E., Janssen, P. M., Schotte, A., Luyten, W. H., &. Megens, A. A. (1993). Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors. Psychopharmacology, 112, S40-S54.
-
(1993)
Psychopharmacology
, vol.112
-
-
Leysen, J.E.1
Janssen, P.M.2
Schotte, A.3
Luyten, W.H.4
Megens, A.A.5
-
10
-
-
0028587855
-
Risperidone in the treatment of pervasive developmental disorder
-
Purdon, S. E., Lit, W., Labelle, A., & Jones, B. D. W. (1994). Risperidone in the treatment of pervasive developmental disorder. Canadian Journal of Psychiatry, 39, 400-405.
-
(1994)
Canadian Journal of Psychiatry
, vol.39
, pp. 400-405
-
-
Purdon, S.E.1
Lit, W.2
Labelle, A.3
Jones, B.D.W.4
-
11
-
-
0019171263
-
Diagnosis of psychiatric disorder in the severely and profoundly retarded patient
-
Reid, A. H. (1980). Diagnosis of psychiatric disorder in the severely and profoundly retarded patient. Journal of the Royal Society of Medicine, 73, 607-609.
-
(1980)
Journal of the Royal Society of Medicine
, vol.73
, pp. 607-609
-
-
Reid, A.H.1
-
12
-
-
0010165474
-
Neuroleptic medications for persons with developmental disabilities
-
M. G. Aman & N. N. Singh (Eds.), New York: Springer-Verlag
-
Schroeder, S. R. (1988). Neuroleptic medications for persons with developmental disabilities. In M. G. Aman & N. N. Singh (Eds.), Psychopharmacology of the developmental disabilities (pp. 82-100). New York: Springer-Verlag.
-
(1988)
Psychopharmacology of the Developmental Disabilities
, pp. 82-100
-
-
Schroeder, S.R.1
-
13
-
-
0004263670
-
-
New York: Slosson Educational Publications
-
Slosson, R. l. (1985). Slosson Intelligence Test. New York: Slosson Educational Publications.
-
(1985)
Slosson Intelligence Test
-
-
Slosson, R.L.1
-
14
-
-
0023037341
-
Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons
-
Sovner, R. (1986). Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons. Psychopharmacology Bulletin, 22, 1055-1059.
-
(1986)
Psychopharmacology Bulletin
, vol.22
, pp. 1055-1059
-
-
Sovner, R.1
-
15
-
-
0003895711
-
-
Circle Pines, MN: American Guidance Services
-
Sparrow, S. S., Balla, D. A., & Cicchetti, D. V. (1984). Vineland Adaptive Behavior Scales: Interview edition. Circle Pines, MN: American Guidance Services.
-
(1984)
Vineland Adaptive Behavior Scales: Interview Edition
-
-
Sparrow, S.S.1
Balla, D.A.2
Cicchetti, D.V.3
-
16
-
-
0027478425
-
Risperidone as add-on therapy in behavioral disturbances in mental retardation: A double blind placebo-controlled cross-over study
-
Vanden Borre, R., Vermote, R., Buttiens, M., Thiry, P., Geutjens, J., Sieben, G., & Heylen, S. (1993). Risperidone as add-on therapy in behavioral disturbances in mental retardation: A double blind placebo-controlled cross-over study. Acta Psychiatrica Scandanavica, 87, 167-171.
-
(1993)
Acta Psychiatrica Scandanavica
, vol.87
, pp. 167-171
-
-
Vanden Borre, R.1
Vermote, R.2
Buttiens, M.3
Thiry, P.4
Geutjens, J.5
Sieben, G.6
Heylen, S.7
|